Emmanuel Briend

Immunology and Microbiology · Life Sciences

9h-index450citations37works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(15), Cell death mechanisms and regulation(9), NF-κB Signaling Pathways(9), Monoclonal and Polyclonal Antibodies Research(6), Glycosylation and Glycoproteins Research(4)

Publications37 total

Figure S4 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Data from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S1 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Table S2 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S2 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S3 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S6 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Table S3 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Table S1 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S7 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S8 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S5 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
Cancer Immunology Research·2025
1355 AGEN1721, a first-in-class Fc-enhanced bifunctional antibody targeting FAP and TGFβ, remodels the tumor microenvironment to overcome cancer-associated fibroblast-mediated immune suppression
Regular and Young Investigator Award Abstracts·2024Open Access
Abstract 3915: BMS-986442 (AGEN1777), a novel TIGIT/CD96 bispecific antibody, demonstrates superior monotherapy and combination activity versus conventional anti-TIGIT antibodies in preclinical models
Cancer Research·2024· 1 cited
Abstract 2906: AGEN1571 is a novel high-affinity ILT2 antagonist antibody that promotes adaptive and innate immune responses
Cancer Research·2022· 3 cited
Proteomic analysis in primary T cells reveals IL-7 alters T cell receptor thresholding via CYTIP/cytohesin/LFA-1 localisation and activation.
Apollo (University of Cambridge)·2022· 2 citedOpen Access
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
Respiratory Research·2017· 30 citedOpen Access
Crystal structure of IgE Fc in complex with a neutralizing antibody
2015
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma
mAbs·2014· 52 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Dhan Chand(16), Olga Ignatovich(15), Priyadarshini Iyer(14), Justin G. Keith(14), Vignesh Venkatraman(14), John Pravin(14), Efrat Altman-Sharoni(13), Xavier Michelet(13), Martyna Popis(13), Reed Masakayan(13), Jin San Choi(13), Stephanie Sanders(13), Alvaro Sebastian-Yague(13), Shannon K. Boi(13), Moira Pinzan-Rossi(13), Georgios Antonopoulos(13), Paul Ibbett(13), Olivier Le Tonquèze(13), Nick Kushner(13), Kah Teong Soh(13)